EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between ABO Blood Groups and SARS-CoV-2 RNAemia, Spike Protein Mutations, and Thrombotic Events in COVID-19 Patients

Esra'a Abudouleh iD, Tarek Owaidah, Fatimah Alhamlan iD, Arwa A Al-Qahtani, Dalia Al Sarar, Abdulrahman Alkathiri iD, Shouq Alghannam, Arwa Bagasi, Manal M Alkhulaifi iD, Ahmed A Al-Qahtani iD

Pathogens · 2025

DOI: 10.3390/pathogens14080758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Esra'a Abudouleh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: ABO Blood-Group System, COVID-19, Thrombosis, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Salman Center for Disability Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 is associated with coagulopathy and increased mortality. The ABO blood group system has been implicated in modulating susceptibility to SARS-CoV-2 infection and disease severity, but its relationship with viral RNAemia, spike gene mutations, and thrombosis remains underexplored.

Methods

We analyzed 446 hospitalized COVID-19 patients between 2021 and 2022. SARS-CoV-2 RNAemia was assessed via RT-qPCR on whole blood, and spike gene mutations were identified through whole-genome sequencing in RNAemia-positive samples. ABO blood groups were determined by agglutination testing, and thrombotic events were evaluated using coagulation markers. Statistical analyses included chi-square tests and Kruskal–Wallis tests, with significance set at p < 0.05.

Results

RNAemia was detected in 26.9% of patients, with no significant association with ABO blood group (p = 0.175). Omicron was the predominant variant, especially in blood group A (62.5%). The N501Y mutation was the most prevalent in group O (53.2%), and K417N was most prevalent in group B (36.9%), though neither reached statistical significance. Thrombotic events were significantly more common in blood group A (OR = 2.08, 95% CI = 1.3–3.4, p = 0.002), particularly among RNAemia-positive patients.

Conclusions

ABO blood group phenotypes, particularly group A, may influence thrombotic risk in the context of SARS-CoV-2 RNAemia. While no direct association was found between blood group and RNAemia or spike mutations, the observed trends suggest potential host–pathogen interactions. Integrating ABO typing and RNAemia screening may enhance risk stratification and guide targeted thromboprophylaxis in COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ABO Blood-Group SystemCOVID-19ThrombosisSARS-CoV-2Spike Glycoprotein, CoronavirusRNA, ViralHumansMaleFemaleMiddle AgedMutationAgedAdult

Stichwörter der Autor:innen

ABO blood groupSARS-CoV-2 RNAemiaSARS-CoV-2 variantsspike gene mutationsthrombosis

Substanzen

ABO Blood-Group SystemSpike Glycoprotein, CoronavirusRNA, Viralspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
  • Department of Pathology, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Department of Infection and Immunity, Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
  • Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Department of Family Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia.

ORCID-Profile: Esra'a Abudouleh, Fatimah Alhamlan, Abdulrahman Alkathiri, Manal M Alkhulaifi, Ahmed A Al-Qahtani

Förderung

  • King Salman Center for Disability Research

Zitieren

APA

Abudouleh, E., Owaidah, T., Alhamlan, F., Al-Qahtani, A. A., Al Sarar, D., Alkathiri, A., Alghannam, S., Bagasi, A., Alkhulaifi, M. M., & Al-Qahtani, A. A. (2025). Association Between ABO Blood Groups and SARS-CoV-2 RNAemia, Spike Protein Mutations, and Thrombotic Events in COVID-19 Patients. Pathogens. https://doi.org/10.3390/pathogens14080758

Vancouver

Abudouleh E, Owaidah T, Alhamlan F, Al-Qahtani AA, Al Sarar D, Alkathiri A, et al. Association Between ABO Blood Groups and SARS-CoV-2 RNAemia, Spike Protein Mutations, and Thrombotic Events in COVID-19 Patients. Pathogens. 2025. doi:10.3390/pathogens14080758

BibTeX
@article{Abudouleh2025,
  author = {Abudouleh, Esra'a and Owaidah, Tarek and Alhamlan, Fatimah and Al-Qahtani, Arwa A and Al Sarar, Dalia and Alkathiri, Abdulrahman and Alghannam, Shouq and Bagasi, Arwa and Alkhulaifi, Manal M and Al-Qahtani, Ahmed A},
  title = {Association Between ABO Blood Groups and SARS-CoV-2 RNAemia, Spike Protein Mutations, and Thrombotic Events in COVID-19 Patients},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14080758}
}
Kostenlos starten →